TROP2 / TACSTD2 Antibody
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry (general), Immunohistochemistry, Paraffin |
| Reactivity: | Human |
| Format: | Liquid |
$179.00each
Catalog Number: LS-C489657-20
Catalog Number: LS-C489657
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- TACSTD2 antibody LS-C489657 is an unconjugated mouse monoclonal antibody to human TACSTD2 (TROP2). Validated for ELISA, Flow and IHC. Cited in 2 publications.
- Application
- ELISA, FC, IHC, IHC-P
- Reactivity
- Hu
- Nonreactive Species
- Ms, Rt
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- EGP-1 | EGP1 | GA7331 | M1S1 | TROP2 | Epithelial glycoprotein-1 | GA733-1 | gp50 | TACSTD2
- Recommended Dilution: ELISA
- 1:1000 - 1:2000
- Recommended Dilution: FC
- 1:25 - 1:100
- Recommended Dilution: IHC-P
- 1:100 - 1:500
- UniProt Number
- P09758
- NCBI GenBank
- NM_002353, NP_002344.2
- SwissProt
- P09758
Target
- Target
- Human TROP2 / TACSTD2
- Antigen Species
- Hu
- Epitope
- Human TROP2 / TACSTD2No cross-reactivity in WB and ELISA with Human BCAM / CD239 Human VCAM1 / CD106 Human ICAM1 / CD54 Human CD146 / MCAM / MUC18 Human CD171 / NCAML1 / L1CAM Human Cadherin-1 / E-cadherin / CDH1 / CD324 Human cell lysate (293 cell line)
- Gene Name
- TACSTD2
Antibody
- Host Species
- Ms
- Clonality
- Monoclonal
Immunogen
- Immunogen
- Recombinant Human TROP2 protein
- Immunogen Type
- Recom
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- 0.2 µm filtered solution in PBS
- Volume
- 20 Microliter
- Preservative
- No
Storage & Handling
- Storage Conditions
- Store at 4°C if intended for use within 1 month, otherwise, store at -20°C to -80°C.
- Recommended Storage Buffer
- PBS
Development and characterization of TrMab-6, a novel anti-TROP2 monoclonal antibody for antigen detection in breast cancer. Yusuke Sayama, Mika K Kaneko, Yukinari Kato. Molecular medicine reports. 2021 February;23:1. PubMed: 33300065 PMC: PMC7723163